Imidazo[1,2-]pyridine-based tosylhydrazone was prepared and treated with K 2 CO 3 in dioxane at 110 ∘ C to generate the corresponding carbene in situ. It was coupled with a variety of aryl alcohols in one pot to obtain a series of imidazo[1,2-]pyridine derivatives possessing aryl ether moiety at C-3 position.
Introduction
Imidazopyridines are important class of heterocyclic compounds. Synthesis of imidazo [1,2-a] pyridine derivatives has been the subject of considerable interest because of their wide range of pharmaceutical, biological, and medicinal applications [1] [2] [3] . e derivatives of this scaffold show a variety of therapeutic properties such as agonist of benzodiazepine receptor [4] , GABA A 2/ 3 binding site agonists [5] , ligand for detecting -amyloid [6] and also constitute orally active nonpeptide bradykinin B 2 receptor antagonists [7] . ese derivatives have been found to possess antibacterial [8] , antiviral [9, 10] , anti-in�ammatory [11] , antiulcer [12] , antitubercular [13] , anticancer [14] , antiparasitic [15] , and antiprotozoa [16] activities, and so forth Moreover, it is also a core structure of several drugs such as zolimidine (1) (antiulcer), alpidem (2) (anxiolytic), and zolpidem (3) (selective benzodiazepine receptor agonist, for the treatment of insomnia) [17] (Figure 1 ) which are currently available in the market. As a result, various methods for the preparation of imidazo [1,2-a] pyridine derivatives were developed [18] [19] [20] . Gueiffier and coworkers reported that imidazo [1,2-a] pyridine derivatives particularly bearing a thioether side chain at 3-position were found to be very active against human cytomegalovirus (HCMV) and varicella-zoster virus (VZV) [9, 10] . In view of signi�cant importance of 3-substituted imidazo [1,2-a]pyridine derivatives herein we report a convenient preparation of imidazo[1,2-a]pyridine derivatives possessing an aryl ether moiety at C-3 position.
Experimental Section
2.1. General. All the chemicals used were purchased from Aldrich Chemical Co and were used without further puri�ca-tion. Freshly distilled solvents were used. For TLC, aluminum plates coated with silica gel containing F254 indicator were used, and the spots were visualized by UV light and/or by exposing to iodine. Column chromatography was performed on silica gel 100-200 mesh, using EtOAc and hexanes mixture as eluent. e 1 H and 13 C spectra were recorded using 5 mm tubes on a Bruker 400 MHz NMR spectrometer �eld strengths: 400 and 100 MHz, resp. in CDCl 3 solution (unless speci�ed otherwise) with shi�s referenced to SiMe 4 ( 1 H, 13 C: ), respectively. All values were in Hz. IR spectra were recorded on a JASCO FT/IR 5300 spectrometer. Elemental (C, H, N) analysis was done using Perkin-Elmer 240C CHN FLASH EA analyzer. Melting points were determined by using a SUPERFIT hot-stage melting point apparatus and are uncorrected.
4-Methyl-N′-{(2-phenylimidazo[1,2-a]pyridine-3-yl)methylene}benzenesulfonohydrazide (8).
To a rapidly stirred suspension of toluenesulfonyl hydrazide (4.6 g, 24.7 mmol) in methanol (10 mL) a solution of aldehyde 7 (5 g, 22.5 mmol) [1,2-a] pyridine (10a). An oven-dried 10 mL round bottom �as� was charged with tosylhydrazone 8 (391 mg, 1.0 mmol), p-cresol (216 mg, 2.0 mmol), and K 2 CO 3 (483 mg, 3.5 equiv). e �as� was evacuated for 5 min and �lled with N 2 . To this dioxane (4 mL) was added and contents were stirred at 110 ∘ C for 12 h under nitrogen. Aer completion of the reaction (monitored by TLC), the mixture was cooled to room temperature and the solvent was evaporated by rotary evaporator to obtain the crude reaction mixture. To this, saturated solution of NaOH (5 mL) and dichloromethane (15 mL) were added subsequently and the layers were separated. e aqueous phase was extracted with dichloromethane (2 × 5 mL). e combined organic layers were washed with NaOH solution (2 × 5 mL), brine (3 × 5 mL) and then dried over anhydrous Na 2 SO 4 . e crude product was puri�ed by column chromatography (hexane:EtOAc 6 : 4) to afford 10a. [1,2-a] 
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Results and Discussion
Towards the synthesis of 3-substituted imidazo[1,2-a]pyridine derivatives, we were attracted by recent reports on the use of tosylhydrazones in C-C and C-O bond formation under metal-free reaction conditions [21] [22] [23] [24] .
2-Phenyl-imidazo[1,2-a]pyridine 6 was synthesized by re�uxing 2-aminopyridine 4 and bromoacetophenone 5 in ethanol for 4 h. Vilsmeier-Haack formylation of 6 provided aldehyde 7 [9, 10] in excellent yield. Treatment of 7 with tosylhydrazide lead to the required hydrozone precursor 8 which was used for etheri�cation reaction (Scheme 1).
�e �rst examined the reaction of tosyl hydrazone 8 with p-cresol 9a in the presence of K 2 CO 3 as a base in dioxane solvent at 110 ∘ C. �e were pleased to �nd that the reaction proceeded smoothly to afford the corresponding ether, 10a in 95% yield. e scope of the reaction was further carried out using various monosubstituted phenols (Table 1 entries 1-5) . Irrespective of the electronic and steric factors of the substituents all the reactions provided the corresponding ethers (10b-10f) in excellent yield (73-88%). Similarly, the disubstituted phenols (Table 1 entries 
Conclusion
In conclusion, we have demonstrated a convenient method for the synthesis of C-3 aryl ether derivatives of imidazo[1,2-a]pyridine via insertion reaction of in situ generated diazocompound with various phenols. is method is fairly general and provides access for the synthesis of aryl ether imidazo[1,2-a]pyridine compounds. e bioactivity assays of these derivatives against HCV and VZV are under progress.
